Compare IBIO & NAMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IBIO | NAMM |
|---|---|---|
| Founded | 2008 | 2024 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.4M | 49.4M |
| IPO Year | 2009 | N/A |
| Metric | IBIO | NAMM |
|---|---|---|
| Price | $2.49 | $2.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.75 | N/A |
| AVG Volume (30 Days) | 995.4K | ★ 2.0M |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $109.93 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $0.91 |
| 52 Week High | $5.60 | $27.78 |
| Indicator | IBIO | NAMM |
|---|---|---|
| Relative Strength Index (RSI) | 50.87 | 45.45 |
| Support Level | $0.78 | $2.80 |
| Resistance Level | $3.01 | $3.75 |
| Average True Range (ATR) | 0.27 | 0.34 |
| MACD | -0.04 | -0.11 |
| Stochastic Oscillator | 23.46 | 4.19 |
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Namib Minerals is a gold producer, developer and explorer with operations focused in Zimbabwe.